0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sepsis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-7A9350
Home | Market Reports | Health| Health Conditions
Global Sepsis Treatment Market Size Status and Forecast 2022
BUY CHAPTERS

Sepsis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-7A9350
Report
April 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sepsis Treatment - Market Size

The global market for Sepsis Treatment was estimated to be worth US$ 3352.9 million in 2023 and is forecast to a readjusted size of US$ 5307.4 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030

Sepsis Treatment - Market

Sepsis Treatment - Market

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sepsis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sepsis Treatment by region & country, by Type, and by Application.
The Sepsis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Treatment.
Market Segmentation

Scope of Sepsis Treatment - Market Report

Report Metric Details
Report Name Sepsis Treatment - Market
Forecasted market size in 2030 US$ 5307.4 million
CAGR 6.7%
Forecasted years 2024 - 2030
Segment by Type:
  • Cephalosporin
  • Pencillin
  • Macrolides
  • Others
Segment by Application
  • Sepsis
  • Severe Sepsis
  • Septic Shock
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA, Mylan, Allergan, Merck & Co, Asahi Kasei Corporation, AtoxBio, INOTREM, Adrenomed, Endacea
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sepsis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Sepsis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Sepsis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sepsis Treatment - Market size in 2030?

Ans: The Sepsis Treatment - Market size in 2030 will be US$ 5307.4 million.

What is the Pfizer share in Sepsis Treatment - Market?

Ans: Pfizer accounted for largest market share of about 3% in 2019.

Who are the main players in the Sepsis Treatment - Market report?

Ans: The main players in the Sepsis Treatment - Market are Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA, Mylan, Allergan, Merck & Co, Asahi Kasei Corporation, AtoxBio, INOTREM, Adrenomed, Endacea

What are the Application segmentation covered in the Sepsis Treatment - Market report?

Ans: The Applications covered in the Sepsis Treatment - Market report are Sepsis, Severe Sepsis, Septic Shock

What are the Type segmentation covered in the Sepsis Treatment - Market report?

Ans: The Types covered in the Sepsis Treatment - Market report are Cephalosporin, Pencillin, Macrolides, Others

1 Market Overview
1.1 Sepsis Treatment Product Introduction
1.2 Global Sepsis Treatment Market Size Forecast
1.3 Sepsis Treatment Market Trends & Drivers
1.3.1 Sepsis Treatment Industry Trends
1.3.2 Sepsis Treatment Market Drivers & Opportunity
1.3.3 Sepsis Treatment Market Challenges
1.3.4 Sepsis Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sepsis Treatment Players Revenue Ranking (2023)
2.2 Global Sepsis Treatment Revenue by Company (2019-2024)
2.3 Key Companies Sepsis Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sepsis Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Sepsis Treatment
2.6 Sepsis Treatment Market Competitive Analysis
2.6.1 Sepsis Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sepsis Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cephalosporin
3.1.2 Pencillin
3.1.3 Macrolides
3.1.4 Others
3.2 Global Sepsis Treatment Sales Value by Type
3.2.1 Global Sepsis Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sepsis Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Sepsis Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sepsis
4.1.2 Severe Sepsis
4.1.3 Septic Shock
4.2 Global Sepsis Treatment Sales Value by Application
4.2.1 Global Sepsis Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sepsis Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Sepsis Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sepsis Treatment Sales Value by Region
5.1.1 Global Sepsis Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sepsis Treatment Sales Value by Region (2019-2024)
5.1.3 Global Sepsis Treatment Sales Value by Region (2025-2030)
5.1.4 Global Sepsis Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sepsis Treatment Sales Value, 2019-2030
5.2.2 North America Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sepsis Treatment Sales Value, 2019-2030
5.3.2 Europe Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sepsis Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sepsis Treatment Sales Value, 2019-2030
5.5.2 South America Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sepsis Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sepsis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sepsis Treatment Sales Value
6.3 United States
6.3.1 United States Sepsis Treatment Sales Value, 2019-2030
6.3.2 United States Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sepsis Treatment Sales Value, 2019-2030
6.4.2 Europe Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sepsis Treatment Sales Value, 2019-2030
6.5.2 China Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sepsis Treatment Sales Value, 2019-2030
6.6.2 Japan Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sepsis Treatment Sales Value, 2019-2030
6.7.2 South Korea Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sepsis Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sepsis Treatment Sales Value, 2019-2030
6.9.2 India Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sepsis Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Sepsis Treatment Products, Services and Solutions
7.1.4 Pfizer Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 NCPC
7.2.1 NCPC Profile
7.2.2 NCPC Main Business
7.2.3 NCPC Sepsis Treatment Products, Services and Solutions
7.2.4 NCPC Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 NCPC Recent Developments
7.3 Bayer
7.3.1 Bayer Profile
7.3.2 Bayer Main Business
7.3.3 Bayer Sepsis Treatment Products, Services and Solutions
7.3.4 Bayer Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Shanghai Pharmaceuticals Recent Developments
7.4 Shanghai Pharmaceuticals
7.4.1 Shanghai Pharmaceuticals Profile
7.4.2 Shanghai Pharmaceuticals Main Business
7.4.3 Shanghai Pharmaceuticals Sepsis Treatment Products, Services and Solutions
7.4.4 Shanghai Pharmaceuticals Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Shanghai Pharmaceuticals Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Profile
7.5.2 Johnson & Johnson Main Business
7.5.3 Johnson & Johnson Sepsis Treatment Products, Services and Solutions
7.5.4 Johnson & Johnson Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Johnson & Johnson Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Sepsis Treatment Products, Services and Solutions
7.6.4 Novartis Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Profile
7.7.2 GlaxoSmithKline Main Business
7.7.3 GlaxoSmithKline Sepsis Treatment Products, Services and Solutions
7.7.4 GlaxoSmithKline Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 GlaxoSmithKline Recent Developments
7.8 TEVA
7.8.1 TEVA Profile
7.8.2 TEVA Main Business
7.8.3 TEVA Sepsis Treatment Products, Services and Solutions
7.8.4 TEVA Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 TEVA Recent Developments
7.9 Mylan
7.9.1 Mylan Profile
7.9.2 Mylan Main Business
7.9.3 Mylan Sepsis Treatment Products, Services and Solutions
7.9.4 Mylan Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Mylan Recent Developments
7.10 Allergan
7.10.1 Allergan Profile
7.10.2 Allergan Main Business
7.10.3 Allergan Sepsis Treatment Products, Services and Solutions
7.10.4 Allergan Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Allergan Recent Developments
7.11 Merck & Co
7.11.1 Merck & Co Profile
7.11.2 Merck & Co Main Business
7.11.3 Merck & Co Sepsis Treatment Products, Services and Solutions
7.11.4 Merck & Co Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Merck & Co Recent Developments
7.12 Asahi Kasei Corporation
7.12.1 Asahi Kasei Corporation Profile
7.12.2 Asahi Kasei Corporation Main Business
7.12.3 Asahi Kasei Corporation Sepsis Treatment Products, Services and Solutions
7.12.4 Asahi Kasei Corporation Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Asahi Kasei Corporation Recent Developments
7.13 AtoxBio
7.13.1 AtoxBio Profile
7.13.2 AtoxBio Main Business
7.13.3 AtoxBio Sepsis Treatment Products, Services and Solutions
7.13.4 AtoxBio Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 AtoxBio Recent Developments
7.14 INOTREM
7.14.1 INOTREM Profile
7.14.2 INOTREM Main Business
7.14.3 INOTREM Sepsis Treatment Products, Services and Solutions
7.14.4 INOTREM Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 INOTREM Recent Developments
7.15 Adrenomed
7.15.1 Adrenomed Profile
7.15.2 Adrenomed Main Business
7.15.3 Adrenomed Sepsis Treatment Products, Services and Solutions
7.15.4 Adrenomed Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Adrenomed Recent Developments
7.16 Endacea
7.16.1 Endacea Profile
7.16.2 Endacea Main Business
7.16.3 Endacea Sepsis Treatment Products, Services and Solutions
7.16.4 Endacea Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Endacea Recent Developments
8 Industry Chain Analysis
8.1 Sepsis Treatment Industrial Chain
8.2 Sepsis Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sepsis Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Sepsis Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sepsis Treatment Market Trends
    Table 2. Sepsis Treatment Market Drivers & Opportunity
    Table 3. Sepsis Treatment Market Challenges
    Table 4. Sepsis Treatment Market Restraints
    Table 5. Global Sepsis Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sepsis Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Sepsis Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Sepsis Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Sepsis Treatment
    Table 10. Global Sepsis Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Sepsis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Sepsis Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Sepsis Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Sepsis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Sepsis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Sepsis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Sepsis Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Sepsis Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Sepsis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Sepsis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Sepsis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Sepsis Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Sepsis Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Sepsis Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Sepsis Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Sepsis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Sepsis Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Sepsis Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Sepsis Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Sepsis Treatment Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. NCPC Basic Information List
    Table 37. NCPC Description and Business Overview
    Table 38. NCPC Sepsis Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Sepsis Treatment Business of NCPC (2019-2024)
    Table 40. NCPC Recent Developments
    Table 41. Bayer Basic Information List
    Table 42. Bayer Description and Business Overview
    Table 43. Bayer Sepsis Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Sepsis Treatment Business of Bayer (2019-2024)
    Table 45. Bayer Recent Developments
    Table 46. Shanghai Pharmaceuticals Basic Information List
    Table 47. Shanghai Pharmaceuticals Description and Business Overview
    Table 48. Shanghai Pharmaceuticals Sepsis Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Sepsis Treatment Business of Shanghai Pharmaceuticals (2019-2024)
    Table 50. Shanghai Pharmaceuticals Recent Developments
    Table 51. Johnson & Johnson Basic Information List
    Table 52. Johnson & Johnson Description and Business Overview
    Table 53. Johnson & Johnson Sepsis Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Sepsis Treatment Business of Johnson & Johnson (2019-2024)
    Table 55. Johnson & Johnson Recent Developments
    Table 56. Novartis Basic Information List
    Table 57. Novartis Description and Business Overview
    Table 58. Novartis Sepsis Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Sepsis Treatment Business of Novartis (2019-2024)
    Table 60. Novartis Recent Developments
    Table 61. GlaxoSmithKline Basic Information List
    Table 62. GlaxoSmithKline Description and Business Overview
    Table 63. GlaxoSmithKline Sepsis Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Sepsis Treatment Business of GlaxoSmithKline (2019-2024)
    Table 65. GlaxoSmithKline Recent Developments
    Table 66. TEVA Basic Information List
    Table 67. TEVA Description and Business Overview
    Table 68. TEVA Sepsis Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Sepsis Treatment Business of TEVA (2019-2024)
    Table 70. TEVA Recent Developments
    Table 71. Mylan Basic Information List
    Table 72. Mylan Description and Business Overview
    Table 73. Mylan Sepsis Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Sepsis Treatment Business of Mylan (2019-2024)
    Table 75. Mylan Recent Developments
    Table 76. Allergan Basic Information List
    Table 77. Allergan Description and Business Overview
    Table 78. Allergan Sepsis Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Sepsis Treatment Business of Allergan (2019-2024)
    Table 80. Allergan Recent Developments
    Table 81. Merck & Co Basic Information List
    Table 82. Merck & Co Description and Business Overview
    Table 83. Merck & Co Sepsis Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Sepsis Treatment Business of Merck & Co (2019-2024)
    Table 85. Merck & Co Recent Developments
    Table 86. Asahi Kasei Corporation Basic Information List
    Table 87. Asahi Kasei Corporation Description and Business Overview
    Table 88. Asahi Kasei Corporation Sepsis Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Sepsis Treatment Business of Asahi Kasei Corporation (2019-2024)
    Table 90. Asahi Kasei Corporation Recent Developments
    Table 91. AtoxBio Basic Information List
    Table 92. AtoxBio Description and Business Overview
    Table 93. AtoxBio Sepsis Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Sepsis Treatment Business of AtoxBio (2019-2024)
    Table 95. AtoxBio Recent Developments
    Table 96. INOTREM Basic Information List
    Table 97. INOTREM Description and Business Overview
    Table 98. INOTREM Sepsis Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Sepsis Treatment Business of INOTREM (2019-2024)
    Table 100. INOTREM Recent Developments
    Table 101. Adrenomed Basic Information List
    Table 102. Adrenomed Description and Business Overview
    Table 103. Adrenomed Sepsis Treatment Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Sepsis Treatment Business of Adrenomed (2019-2024)
    Table 105. Adrenomed Recent Developments
    Table 106. Endacea Basic Information List
    Table 107. Endacea Description and Business Overview
    Table 108. Endacea Sepsis Treatment Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Sepsis Treatment Business of Endacea (2019-2024)
    Table 110. Endacea Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Sepsis Treatment Downstream Customers
    Table 114. Sepsis Treatment Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Sepsis Treatment Product Picture
    Figure 2. Global Sepsis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sepsis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Sepsis Treatment Report Years Considered
    Figure 5. Global Sepsis Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Sepsis Treatment Revenue in 2023
    Figure 7. Sepsis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Cephalosporin Picture
    Figure 9. Pencillin Picture
    Figure 10. Macrolides Picture
    Figure 11. Others Picture
    Figure 12. Global Sepsis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Sepsis Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Sepsis
    Figure 15. Product Picture of Severe Sepsis
    Figure 16. Product Picture of Septic Shock
    Figure 17. Global Sepsis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Sepsis Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Sepsis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Sepsis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Sepsis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Sepsis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Sepsis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Sepsis Treatment Sales Value (%), (2019-2030)
    Figure 30. United States Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Sepsis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Sepsis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 51. Sepsis Treatment Industrial Chain
    Figure 52. Sepsis Treatment Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Clotting Factors Ⅷ Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-21S8513
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Rare Genetic Disease Diagnosis Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17L15214
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Endoscopes for Otology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19V14797
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart